Shikha Wadhwani MD MS
Glomerular Disease, Hypertension
Assistant Professor Northwestern University Feinberg School of Medicine
Join to View Full Profile
675 N Saint Clair StFl 18Chicago, IL 60611
Phone+1 312-695-0596
Fax+1 312-695-5232
Dr. Wadhwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shikha Wadhwani is Director of the Glomerular Disease Program at Northwestern University's Feinberg School of Medicine and an Assistant professor in the Division of Nephrology and Hypertension. She is also Program Director for the Glomerular disease fellowship and cofounder of the joint Rheum-Renal Lupus Nephritis clinic at Northwestern. She is committed to providing comprehensive care to patients, and has a clinical interest in glomerulonephritis, vasculitis, and pregnancy-related kidney disease. Her research focuses on clinical outcomes of glomerular diseases in the NIH-funded CureGN cohort. She is site PI/Co-I for clinical trials aimed at investigating novel therapeutics for patients with glomerular disease. She has served on numerous medical advisory boards and spoken in various regional, national, and international forums about lupus nephritis and IgA nephropathy.
Education & Training
Ohio State University Wexner Medical CenterFellowship in Glomerular Diseases, 2016 - 2017
Rush University Medical CenterFellowship, Nephrology, 2013 - 2016- Rush UniversityMS, Clinical Research , 2013 - 2016
- Rush University Medical CenterResidency, Internal Medicine, 2011 - 2013
Cook County Health and Hospitals SystemInternship, Internal Medicine, 2010 - 2011
Rush Medical College of Rush University Medical CenterClass of 2010
Certifications & Licensure
IL State Medical License 2013 - 2026
OH State Medical License 2016 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Clinical Trials
- An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis Start of enrollment: 2019 Jul 15
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy Start of enrollment: 2018 Sep 05
- Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) Start of enrollment: 2020 Nov 17
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsLiver Disease-Associated Glomerulopathies.Swetha R Kanduri, Yonatan Peleg, Shikha Wadhwani
Advances in Kidney Disease and Health. 2024-03-01 - 19 citationsKDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.Laurence H Beck Jr, Isabelle Ayoub, Dawn Caster, Michael J Choi, Jason Cobb
American Journal of Kidney Diseases. 2023-08-01 - CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.Amy K Mottl, Andrew S Bomback, Laura H Mariani, Gaia Coppock, J Charles Jennette
Glomerular Diseases. 2023-06-26
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
